Literature DB >> 9059252

Increased expression of angiogenic growth factors in age-related maculopathy.

M Kliffen1, H S Sharma, C M Mooy, S Kerkvliet, P T de Jong.   

Abstract

AIMS/
BACKGROUND: The late stages of age-related maculopathy (ARM), especially neovascular macular degeneration (ARMD), can severely affect central vision and are the main cause of blindness in the elderly in the Western world. It has been shown that angiogenic growth factors are present in neovascular membranes in ARMD. However, it is not known if angiogenic growth factors play a role in the onset of neovascularisation.
METHODS: In order to elucidate the involvement of angiogenic growth factors in the initiation of neovascularisation in early stages of ARM, the expression patterns of VEGF, TGF-beta, b-FGF, and PDGF-AA on 18 human maculae with ARM, and on 11 control specimens were investigated immunohistochemically.
RESULTS: A significantly increased expression of VEGF (p = 0.00001) and TGF-beta (p = 0.019) was found in the retinal pigment epithelium (RPE) of maculae with ARM compared with control maculae. Furthermore, an increased expression of VEGF and PDGF was found in the outer nuclear layer of maculae with ARM.
CONCLUSION: These results demonstrate an increased expression of VEGF in the RPE, and in the outer nuclear layer in maculae with ARM, that could be involved in the pathogenesis of neovascular macular degeneration. Furthermore, enhanced TGF-beta expression in the RPE cells of maculae with early stages of ARM was shown.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9059252      PMCID: PMC1722110          DOI: 10.1136/bjo.81.2.154

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  50 in total

Review 1.  Angiogenesis inhibition in age-related macular degeneration.

Authors:  R J D'Amato; A P Adamis
Journal:  Ophthalmology       Date:  1995-09       Impact factor: 12.079

2.  Growth factor responsiveness of human retinal pigment epithelial cells.

Authors:  K H Leschey; S F Hackett; J H Singer; P A Campochiaro
Journal:  Invest Ophthalmol Vis Sci       Date:  1990-05       Impact factor: 4.799

3.  Ageing and degeneration in the macular region: a clinico-pathological study.

Authors:  S H Sarks
Journal:  Br J Ophthalmol       Date:  1976-05       Impact factor: 4.638

4.  Evolution of geographic atrophy of the retinal pigment epithelium.

Authors:  J P Sarks; S H Sarks; M C Killingsworth
Journal:  Eye (Lond)       Date:  1988       Impact factor: 3.775

5.  Transforming growth factor type beta induces monocyte chemotaxis and growth factor production.

Authors:  S M Wahl; D A Hunt; L M Wakefield; N McCartney-Francis; L M Wahl; A B Roberts; M B Sporn
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

6.  Pathologic features of senile macular degeneration.

Authors:  W R Green; P J McDonnell; J H Yeo
Journal:  Ophthalmology       Date:  1985-05       Impact factor: 12.079

7.  Retinal pigment epithelial cells release an inhibitor of neovascularization.

Authors:  B M Glaser; P A Campochiaro; J L Davis; M Sato
Journal:  Arch Ophthalmol       Date:  1985-12

8.  Retinal pigment epithelial cells produce PDGF-like proteins and secrete them into their media.

Authors:  P A Campochiaro; R Sugg; G Grotendorst; L M Hjelmeland
Journal:  Exp Eye Res       Date:  1989-08       Impact factor: 3.467

Review 9.  Age-related macular degeneration.

Authors:  N M Bressler; S B Bressler; S L Fine
Journal:  Surv Ophthalmol       Date:  1988 May-Jun       Impact factor: 6.048

Review 10.  Some recent advances in the chemistry and biology of transforming growth factor-beta.

Authors:  M B Sporn; A B Roberts; L M Wakefield; B de Crombrugghe
Journal:  J Cell Biol       Date:  1987-09       Impact factor: 10.539

View more
  131 in total

1.  Dynamics of phosphorothioate oligonucleotides in normal and laser photocoagulated retina.

Authors:  W Y Shen; K L Garrett; L da Cruz; I J Constable; P E Rakoczy
Journal:  Br J Ophthalmol       Date:  1999-07       Impact factor: 4.638

Review 2.  Role of vascular permeability factor/vascular endothelial growth factor in eye disease.

Authors:  R O Schlingemann; V W van Hinsbergh
Journal:  Br J Ophthalmol       Date:  1997-06       Impact factor: 4.638

3.  Suppression of experimental choroidal neovascularization utilizing KDR selective receptor tyrosine kinase inhibitor.

Authors:  Atsunobu Takeda; Yasuaki Hata; Satomi Shiose; Yukio Sassa; Masae Honda; Kimihiko Fujisawa; Taiji Sakamoto; Tatsuro Ishibashi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-08-23       Impact factor: 3.117

4.  Polymorphisms in the VEGF-A in polypoidal choroidal vasculopathy in a Korean population.

Authors:  Dong Ho Park; In Taek Kim
Journal:  Jpn J Ophthalmol       Date:  2012-02-04       Impact factor: 2.447

5.  Subfoveal choroidal thickness in polypoidal choroidal vasculopathy after switching to intravitreal aflibercept injection.

Authors:  Masaaki Saito; Mariko Kano; Kanako Itagaki; Shigeyuki Ise; Kimihiro Imaizumi; Tetsuju Sekiryu
Journal:  Jpn J Ophthalmol       Date:  2015-09-09       Impact factor: 2.447

6.  Expression profile of voltage-dependent Ca2+ channel subunits in the human retinal pigment epithelium.

Authors:  Sönke Wimmers; Linn Coeppicus; Rita Rosenthal; Olaf Strauss
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-02-13       Impact factor: 3.117

Review 7.  Molecular pathology of age-related macular degeneration.

Authors:  Xiaoyan Ding; Mrinali Patel; Chi-Chao Chan
Journal:  Prog Retin Eye Res       Date:  2008-11-06       Impact factor: 21.198

Review 8.  Role of growth factors and the wound healing response in age-related macular degeneration.

Authors:  Reinier O Schlingemann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-12-18       Impact factor: 3.117

9.  Downregulation of p22phox in retinal pigment epithelial cells inhibits choroidal neovascularization in mice.

Authors:  Qiuhong Li; Astra Dinculescu; Zhiying Shan; Rehae Miller; Jijing Pang; Alfred S Lewin; Mohan K Raizada; William W Hauswirth
Journal:  Mol Ther       Date:  2008-07-29       Impact factor: 11.454

10.  Two-year results of combined intravitreal ranibizumab and photodynamic therapy for retinal angiomatous proliferation.

Authors:  Masaaki Saito; Tomohiro Iida; Mariko Kano; Kanako Itagaki
Journal:  Jpn J Ophthalmol       Date:  2016-01       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.